- Home
- IOBT vs EQS Comparison
IOBT vs EQS Comparison
Compare IOBT & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOBT
- EQS
- Stock Information
- Founded
- IOBT 2014
- EQS 1991
- Country
- IOBT Denmark
- EQS United States
- Employees
- IOBT N/A
- EQS N/A
- Industry
- IOBT Biotechnology: Pharmaceutical Preparations
- EQS Finance Companies
- Sector
- IOBT Health Care
- EQS Finance
- Exchange
- IOBT Nasdaq
- EQS Nasdaq
- Market Cap
- IOBT 31.7M
- EQS 33.7M
- IPO Year
- IOBT 2021
- EQS N/A
- Fundamental
- Price
- IOBT $0.52
- EQS $2.17
- Analyst Decision
- IOBT Hold
- EQS
- Analyst Count
- IOBT 3
- EQS 0
- Target Price
- IOBT $4.00
- EQS N/A
- AVG Volume (30 Days)
- IOBT 4.6M
- EQS 21.8K
- Earning Date
- IOBT 11-11-2025
- EQS 01-01-0001
- Dividend Yield
- IOBT N/A
- EQS N/A
- EPS Growth
- IOBT N/A
- EQS N/A
- EPS
- IOBT N/A
- EQS N/A
- Revenue
- IOBT N/A
- EQS $1,355,000.00
- Revenue This Year
- IOBT N/A
- EQS N/A
- Revenue Next Year
- IOBT N/A
- EQS N/A
- P/E Ratio
- IOBT N/A
- EQS N/A
- Revenue Growth
- IOBT N/A
- EQS 60.35
- 52 Week Low
- IOBT $0.32
- EQS $0.74
- 52 Week High
- IOBT $2.79
- EQS $2.49
- Technical
- Relative Strength Index (RSI)
- IOBT 27.94
- EQS 46.03
- Support Level
- IOBT $0.45
- EQS $2.16
- Resistance Level
- IOBT $0.55
- EQS $2.36
- Average True Range (ATR)
- IOBT 0.08
- EQS 0.09
- MACD
- IOBT -0.06
- EQS -0.04
- Stochastic Oscillator
- IOBT 14.13
- EQS 19.40
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.